Paving the way for early diagnosis and intervention in rare MC4R pathway diseases: VENTURE trial results from age 2

Thursday, 03 April 2025, Virtual

Recording now available

About the webinar
 

Watch this Rhythm sponsored webinar to learn about the VENTURE trial results from 2 years of age and hear Professor Jesús Argente and Professor Carel Le Roux talk about the importance of early diagnosis and intervention in rare melanocortin-4 receptor (MC4R) pathway diseases.
 

KEY TOPICS:

  • Decoding hyperphagia and early-onset obesity
  • How early diagnosis and intervention can help transform paediatric care
  • VENTURE trial: Precision medicine treatment from age 2
  • Deep dive: Advanced insights from the expert
     

Speakers:

Photo of Prof. Carel Le Roux

Prof Carel Le Roux

(Ireland)

Prof Jesús Argente

(Spain)

This webinar is fully organised and funded by Rhythm Pharmaceuticals Netherlands B.V. and is intended for healthcare professionals only. The session will include promotional content on Rhythm products.

Join our community of healthcare professionals

  • Get the latest news
  • Access materials within the Content Hub
  • Hear about upcoming events
  • Receive recommended content based on your interests